New targeted drugs in the pharmacotherapy of rheumatoid arthritis

dc.contributor.advisorMegyeri, Attila
dc.contributor.advisordeptDebreceni Egyetem::Általános Orvostudományi Kar::Farmakológiai és Farmakoterápiai Intézethu_HU
dc.contributor.authorGoldstein, Adam Moshe
dc.contributor.departmentDE--Általános Orvostudományi Karhu_HU
dc.contributor.opponentSzentmiklósi, József András
dc.contributor.opponentDrimba, László
dc.contributor.opponentdeptDebreceni Egyetem::Általános Orvostudományi Kar::Farmakológiai és Farmakoterápiai Intézethu_HU
dc.contributor.opponentdeptKenézy Kórház, Központi Aneszteziológiai és Intezív Terápiás Osztályhu_HU
dc.date.accessioned2022-08-18T10:07:40Z
dc.date.available2022-08-18T10:07:40Z
dc.date.created2021
dc.description.abstractAdvances in biotechnology and spreading of biological therapies during the last three decades resulted in the approval of several new and effective disease modifying treatment options in rheumatoid arthritis.The most effective current treatment of rheumatoid arthritis varies from patient to patient, and a common theme among them is the combined use of a conventional systemic disease modifying agent (csDMARD) plus either a biological (bDMARD) or a targeted systemic (tsDMARD) drug. It is crucial for any physician who deals with rheumatoid arthritis patients to be up to date on the latest information that influences the guidelines of their treatments. There is currently an ever-emerging front for inflammatory and immune modulation therapies. Staying up to date on both the benefits and drawbacks of new therapies will lead to improved patient outcomes in the coming years.hu_HU
dc.description.courseáltalános orvoshu_HU
dc.description.courselangangolhu_HU
dc.description.degreeegységes, osztatlanhu_HU
dc.format.extent31hu_HU
dc.identifier.urihttp://hdl.handle.net/2437/336597
dc.language.isoenhu_HU
dc.subjectRheumatoidhu_HU
dc.subject.dspaceDEENK Témalista::Orvostudomány::Belgyógyászathu_HU
dc.titleNew targeted drugs in the pharmacotherapy of rheumatoid arthritishu_HU
Fájlok